# Primary pleomorphic liposarcoma involving bilateral ovaries: Case report and literature review

**Authors:** Huan Chen, Jing Luo, Ke Zhang, Puxiang Chen

PMC · DOI: 10.1515/biol-2025-1068 · Open Life Sciences · 2025-03-21

## TL;DR

This case report describes a rare instance of primary pleomorphic liposarcoma in a patient's bilateral ovaries and discusses its diagnosis, treatment, and the lack of established guidelines for such cases.

## Contribution

The novelty lies in presenting a rare case of primary pleomorphic liposarcoma in the ovaries and summarizing existing literature to raise awareness.

## Key findings

- Primary pleomorphic liposarcoma involving bilateral ovaries was confirmed through histopathological examination.
- The patient showed significant reduction in CA-125 levels following chemotherapy.
- PLPS in the female reproductive system is rare and often misdiagnosed due to complex pathology and lack of specific markers.

## Abstract

Pleomorphic liposarcomas (PLPSs) commonly occur in the extremities or retroperitoneum. However, cases of primary PLPSs in the female reproductive system are rare, with only one reported case in the ovary. Herein, we describe the case of a patient with primary PLPS involving bilateral ovaries. She presented with a 2-month history of abdominal pain, and underwent total hysterectomy with bilateral salpingo-oophorectomy, omentectomy, and excision of surface lesions on the bladder and rectum. Intraoperatively, nitrogen mustard (2%) was used to rinse the abdominal cavity. One week postoperatively, she was administered the first cycle of postoperative cisplatin chemotherapy for intraperitoneal heat infusion chemotherapy plus intravenous liposomal paclitaxel. Postoperative histopathological examination revealed primary PLPS involving both ovaries. Therefore, a doxorubicin liposomal chemotherapy regimen was administered according to the soft tissue sarcoma NCCN guidelines. The patient’s CA-125 levels decreased from 987 to 9.8 U/mL; however, after two chemotherapy sessions, she declined further treatment. The patient was still being followed-up and had no signs of recurrence at the time of writing this report. PLPS tends to be misdiagnosed and underdiagnosed due to its complex pathology and the lack of specific molecular markers. The disease is infrequent in the female reproductive system, and there is no consensus on its diagnostic and therapeutic guidelines. Herein, we summarized the findings of published case reports of PLPSs in organs of the female reproductive system to raise awareness of the disease and discussed its diagnosis, clinical treatment, and prognosis.

## Linked entities

- **Chemicals:** nitrogen mustard (PubChem CID 4033), cisplatin (PubChem CID 5460033), doxorubicin (PubChem CID 31703)
- **Diseases:** pleomorphic liposarcoma (MONDO:0020562)

## Full-text entities

- **Genes:** MUC16 (mucin 16, cell surface associated) [NCBI Gene 94025] {aka CA125}
- **Diseases:** soft tissue sarcoma (MESH:D012509), PLPSs (MESH:D008080), abdominal pain (MESH:D015746), Primary (MESH:D010538)
- **Chemicals:** paclitaxel (MESH:D017239), doxorubicin (MESH:D004317), cisplatin (MESH:D002945), nitrogen mustard (MESH:D008466)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11931658/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11931658/full.md

---
Source: https://tomesphere.com/paper/PMC11931658